Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about SENESCENCE: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet. View on Wiki →
| Name | SENESCENCE |
| Category | cellular senescence, aging, Alzheimer's, Parkinson's |
| Summary | Cross-disease comparison of cellular senescence mechanisms in Alzheimer's, Parkinson's, ALS, FTD, and Huntington's disease |
| Key Genes/Proteins | AQP4 |
| Related Diseases | Ph-Like ALL |
| Linked Hypotheses | 11 hypotheses |
Knowledge base pages for this entity
graph TD
SENESCENCE["SENESCENCE"] -->|"contributes to"| TUMOR["TUMOR"]
SENESCENCE["SENESCENCE"] -->|"causes"| STING["STING"]
SENESCENCE["SENESCENCE"] -->|"expressed in"| T_CELL["T CELL"]
SENESCENCE["SENESCENCE"] -->|"expressed in"| T_CELLS["T CELLS"]
SENESCENCE["SENESCENCE"] -->|"associated"| T_CELL_1["T CELL"]
SENESCENCE["SENESCENCE"] -->|"associated"| T_CELLS_2["T CELLS"]
ALZHEIMER_S_DISEASE["ALZHEIMER'S DISEASE"] -->|"associated"| SENESCENCE["SENESCENCE"]
NEURODEGENERATION["NEURODEGENERATION"] -->|"associated"| SENESCENCE["SENESCENCE"]
PARKINSON_S_DISEASE["PARKINSON'S DISEASE"] -->|"associated"| SENESCENCE["SENESCENCE"]
NEUROINFLAMMATION["NEUROINFLAMMATION"] -->|"associated"| SENESCENCE["SENESCENCE"]
style SENESCENCE fill:#5d4400,stroke:#4fc3f7,stroke-width:2px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| NEUROINFLAMMATION | associated_with | entity | 0.90 |
| Ph-Like ALL | associated_with | disease | 0.85 |
| ALZHEIMER'S DISEASE | contributes_to | entity | 0.75 |
| PARKINSON'S DISEASE | contributes_to | entity | 0.75 |
| AGE-RELATED NEUROPATHY | contributes_to | entity | 0.75 |
| GLIOMA | modulates | entity | 0.75 |
| AGING | interacts_with | process | 0.72 |
| NEURODEGENERATION | implicated_in | process | 0.72 |
| AGING | implicated_in | process | 0.72 |
| AGING | regulates | process | 0.72 |
| AQP4 | stabilizes | gene | 0.70 |
| LIPID PEROXIDATION | regulates | phenotype | 0.70 |
| DNA DAMAGE RESPONSE | causes | pathway | 0.70 |
| PHAGOCYTOSIS | inhibits | phenotype | 0.70 |
| EGFR | activates | gene | 0.70 |
| STING | mediated_by | gene | 0.65 |
| COGNITIVE DECLINE | causes | phenotype | 0.65 |
| FIBROSIS | targets | disease | 0.65 |
| ANGIOGENESIS | inhibits | phenotype | 0.65 |
| RIBOSOME | activates | organelle | 0.65 |
| MMP2 | inhibits | gene | 0.65 |
| TAU | produces | protein | 0.65 |
| COGNITIVE DECLINE | interacts_with | phenotype | 0.65 |
| NEURODEGENERATION | increases_risk | disease | 0.65 |
| CYTOKINES | produces | phenotype | 0.65 |
| INFLAMMATION | causes | phenotype | 0.65 |
| MITOCHONDRIAL DYSFUNCTION | protects_against | phenotype | 0.65 |
| ABCA1 | regulates | gene | 0.65 |
| STROKE | targets | disease | 0.65 |
| HIPPOCAMPUS | inhibits | brain_region | 0.65 |
| INFLAMMATION | exacerbates | phenotype | 0.65 |
| INFLAMMATION | degrades | phenotype | 0.65 |
| NEUROGENESIS | causes | phenotype | 0.65 |
| NEUROGENESIS | treats | phenotype | 0.65 |
| RIBOSOME | destabilizes | organelle | 0.60 |
| LIPID PEROXIDATION | activates | phenotype | 0.60 |
| LIPID PEROXIDATION | synergizes_with | phenotype | 0.60 |
| AGING | causes | process | 0.58 |
| MITOCHONDRIAL DYSFUNCTION | activates | process | 0.58 |
| WOUND HEALING | implicated_in | phenotype | 0.55 |
| MICROGLIA | expressed_in | cell_type | 0.55 |
| COGNITIVE DECLINE | implicated_in | phenotype | 0.55 |
| ABCA1 | expressed_in | gene | 0.55 |
| AGING | participates_in | phenotype | 0.55 |
| STING | co_discussed | entity | 0.50 |
| T CELL | co_discussed | entity | 0.50 |
| T CELLS | co_discussed | entity | 0.50 |
| STING SIGNALING | regulates | process | 0.50 |
| STEM CELLS | activates | cell_type | 0.50 |
| STEM CELLS | associated_with | cell_type | 0.50 |
| Source | Relation | Type | Str |
|---|---|---|---|
| mitochondrial dysfunction | induces | process | 0.90 |
| STRESS GRANULES | interacts_with | entity | 0.80 |
| SASP | associated_with | entity | 0.80 |
| MICROGLIAL | undergoes | cell_type | 0.80 |
| MICROGLIA | treats | cell_type | 0.70 |
| CGAS | protects_against | gene | 0.70 |
| GPX4 | protects_against | gene | 0.70 |
| GPX4 | activates | gene | 0.70 |
| GPX4 | stabilizes | gene | 0.70 |
| OLIGODENDROCYTE | treats | cell_type | 0.70 |
| SIRT6 | exacerbates | gene | 0.70 |
| SIRT6 | protects_against | gene | 0.70 |
| TERT | protects_against | gene | 0.70 |
| TREM2 | inhibits | gene | 0.70 |
| ENDOTHELIAL CELLS | regulates | cell_type | 0.65 |
| CELL CYCLE | interacts_with | process | 0.65 |
| NEUROINFLAMMATION | mediated_by | process | 0.65 |
| AUTOPHAGY | exacerbates | phenotype | 0.65 |
| AUTOPHAGY | treats | phenotype | 0.65 |
| MAPK PATHWAY | causes | pathway | 0.65 |
| MAPK PATHWAY | activates | pathway | 0.65 |
| SMAD3 | regulates | gene | 0.65 |
| STING PATHWAY | treats | pathway | 0.65 |
| SMAD SIGNALING | regulates | pathway | 0.65 |
| TSC2 | converts | gene | 0.65 |
| TUMOR CELLS | activates | cell_type | 0.65 |
| QUERCETIN | treats | drug | 0.65 |
| QUERCETIN | activates | drug | 0.65 |
| HYDROXYCHLOROQUINE | protects_against | drug | 0.65 |
| ATG5 | activates | gene | 0.65 |
| RAPAMYCIN | inhibits | drug | 0.65 |
| PROTEIN AGGREGATION | interacts_with | phenotype | 0.65 |
| QUERCETIN | inhibits | drug | 0.65 |
| STING | interacts_with | gene | 0.65 |
| MLKL | causes | gene | 0.65 |
| TAU | activates | protein | 0.65 |
| CURCUMIN | regulates | drug | 0.65 |
| SPERMIDINE | treats | drug | 0.65 |
| IL1B | interacts_with | gene | 0.65 |
| MITOCHONDRIAL DYSFUNCTION | treats | phenotype | 0.65 |
| NLRP3 | treats | gene | 0.65 |
| MICROGLIAL ACTIVATION | inhibits | phenotype | 0.65 |
| TFEB | protects_against | gene | 0.65 |
| NEURODEGENERATION | biomarker_for | disease | 0.65 |
| CURCUMIN | protects_against | drug | 0.65 |
| LITHIUM | inhibits | drug | 0.65 |
| GLIOBLASTOMA | activates | disease | 0.65 |
| OLIGODENDROCYTES | causes | cell_type | 0.65 |
| ABCA1 | treats | gene | 0.65 |
| IL1B | targets | gene | 0.65 |
Hypotheses where this entity is a therapeutic target
Scientific analyses that reference this entity
neuroimmunology | 2026-04-15 | 2 hypotheses Top: 0.674
neurodegeneration | 2026-04-15 | 2 hypotheses Top: 0.675
neurodegeneration | 2026-04-14 | 0 hypotheses
cellular senescence | 2026-04-11 | 0 hypotheses
cell biology | 2026-04-08 | 0 hypotheses
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| Klebsiella pneumoniae Induces Ferroptosis and Lactation Dysfunction in Bovine Ma [PMID:40937759] | Mao P, Wang Z, Duan J, Dong P, Yuan C, L | J Agric Food Chem | 2025 | 1 |
| Targeting ferroptosis: novel therapeutic approaches and intervention strategies [PMID:41425591] | Luo Y, Long M, Wu X, Zeng L | Front Immunol | 2025 | 1 |
| Trimetazidine attenuates Ischemia/Reperfusion-Induced myocardial ferroptosis by [PMID:39134283] | Tan M, Yin Y, Chen W, Zhang J, Jin Y, Zh | Biochem Pharmacol | 2024 | 1 |
| Copy number deletion of PLA2G4A affects the susceptibility and clinical phenotyp [PMID:38816399] | Gao Z, Guo X, Sun Z, Wu S, Wang Q, Huang | Schizophrenia (Heidelb) | 2024 | 1 |
| Channeling Nicotinamide Phosphoribosyltransferase (NAMPT) to Address Life and De [PMID:38580317] | Velma GR, Krider IS, Alves ETM, Courey J | J Med Chem | 2024 | 1 |
| Microglia-Mediated Neuroinflammation: A Potential Target for the Treatment of Ca [PMID:35642214] | Wang M, Pan W, Xu Y, Zhang J, Wan J, Jia | J Inflamm Res | 2022 | 1 |
| TREM2, microglia, and Alzheimer's disease. [PMID:33516818] | Qin Q, Teng Z, Liu C, Li Q, Yin Y, Tang | Mech Ageing Dev | 2021 | 1 |
| NAD(+) metabolism, stemness, the immune response, and cancer. [PMID:33384409] | Navas LE, Carnero A | Signal Transduct Target Ther | 2021 | 1 |
| Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2- [PMID:31932797] | Zhou Y, Song WM, Andhey PS, Swain A, Lev | Nat Med | 2020 | 1 |
| NAD metabolism fuels human and mouse intestinal inflammation. [PMID:28877980] | Gerner RR, Klepsch V, Macheiner S, Arnha | Gut | 2018 | 1 |
| TREM2 Maintains Microglial Metabolic Fitness in Alzheimer's Disease. [PMID:28802038] | Ulland TK, Song WM, Huang SC, Ulrich JD, | Cell | 2017 | 1 |
| The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Mic [PMID:28930663] | Krasemann S, Madore C, Cialic R, Baufeld | Immunity | 2017 | 1 |
| NAD+ and sirtuins in aging and disease. [PMID:24786309] | Imai S, Guarente L | Trends Cell Biol | 2014 | 1 |
| Lipoprotein-associated and secreted phospholipases A₂ in cardiovascular disease: [PMID:21098459] | Mallat Z, Lambeau G, Tedgui A | Circulation | 2010 | 1 |
| Phospholipase A2 regulation of bovine endometrial (BEND) cell prostaglandin prod [PMID:18811942] | Godkin JD, Roberts MP, Elgayyar M, Guan | Reprod Biol Endocrinol | 2008 | 1 |
| Precision Neurodegeneration: Integrating Molecular Mechanisms, Biomarkers, and T [PMID:41833042] | ["Lyu G", "Li D"] | CNS & neurological disorders d | 2026 | 0 |
| Emerging pathological mechanisms of Alzheimer's disease pathogenesis: from neuro [PMID:41858793] | ["Wang R", "Feng Y", "Zhou Z", "Jiang J" | Frontiers in aging neuroscienc | 2026 | 0 |
| Human CSF proteogenomics links genetic variation to neurodegenerative disease pr [PMID:41757182] | ["Puerta R", "Garc\u00eda-Gonz\u00e1lez | medRxiv : the preprint server | 2026 | 0 |
| PLCG2 signaling and genetic resilience in Alzheimer's disease. [PMID:41888907] | Tsai AP, Martin AK, Mi A, Yeh AE, Ramire | Molecular neurodegeneration | 2026 | 0 |
| TREM2 deficiency delays postnatal microglial maturation and synaptic pruning, le [PMID:41930604] | Yang HC, Deng YS, Zhang J, Zhang T, Song | J Alzheimers Dis | 2026 | 0 |